| Company type | Health technology |
|---|---|
| Industry | Healthcare |
| Genre | Artificial intelligence |
| Founded | 2013 in Oslo, Norway |
| Headquarters | , |
| Website | www.livehealthily.com |
Your.MD also known as Healthily, is a digital healthtech company that uses artificial intelligence to provide users with personalised health information via a chatbot. [1]
It was founded in Oslo, Norway in 2013 by Henrik Pettersen and now has headquarters in London, England. In June 2017, Your.MD raised $10 million in funding from its series A round, [2] bringing total funding to $19 million. Its current investors include: Smedvig Capital AS, Orkla Group and a number of angel investors. [3]
In August 2019, Reckitt Benckiser announced that they were making a strategic investment in and partnership with the company, [4] and in October 2020 it was reported that they had invested €25 million to roll out its “health hubs” concept.[ citation needed ]
The company reported a 350% increase in the number of users, from 6m users from January to August 2019 to 26 m the same period in 2020, largely attributed to the Your.MD Covid-19 Symptom Mapper. The self-care app was launched in India in September 2020. [5]
In April 2017, Your.MD was awarded the Unesco/Netexplo Award 2017 for “innovations that can improve society”. [6] The app received the ePrivacy seal, meaning that it fully complies with the European laws on privacy. [7]
It entered into a partnership with BMJ Best Practice in May 2018 to validate the medical data used by its AI algorithms. [8]
In October 2017, Your.MD contributed to the UK Government report “Growing the Artificial Intelligence industry in the UK”, and was featured for its presence in the personal health sector. [9]
It has been compared to Babylon's GP at Hand app [10] and Ada Health. In October 2017, when the three apps were tested with symptoms from asthma, shingles, alcohol-related liver disease, and urinary tract infection it failed to diagnose shingles or UTI. At that stage, the symptom checker was in a beta stage, and has since been upgraded. [11]
In June 2020, it was awarded the CogX People's Choice COVID-19 Innovation for Society. [12] It is one of the apps which is used to collect data to help model the evolving threat of COVID-19 across the UK in the OASIS project, [13] working with researchers from Imperial College London. [14]